Table 5 Contributions from studies with enrichment design to mixed and indirect estimates
Depressive episode relapse | Mania episode relapse | |||||
|---|---|---|---|---|---|---|
In favour of the drug to the right (%) | In disfavour of the drug to the right (%) | Enrichment of unknown direction (%) | In favour of the drug to the right (%) | In disfavour of the rug to the right (%) | Enrichment of unknown direction (%) | |
PLB vs LIT | 12.12 | 10.49 | 0.05 | 5.73 | 6.83 | 0.24 |
PLB vs VPA | 5.51 | 0.00 | 4.82 | 3.34 | 0.00 | 4.18 |
PLB vs LTG | 48.26 | 0.00 | 1.94 | 21.75 | 0.00 | 1.51 |
PLB vs IMP | 5.80 | 5.20 | 7.43 | 2.97 | 4.76 | 6.03 |
PLB vs FLX | 68.79 | 0.00 | 3.02 | – | – | – |
PLB vs LIT + IMP | 17.76 | 0.00 | 5.03 | 13.26 | 0.00 | 3.53 |
PLB vs ARP | 0.00 | 0.00 | 0.00 | 99.90 | 0.00 | 0.00 |
PLB vs OLZ | 2.59 | 0.00 | 2.25 | 45.83 | 20.40 | 0.22 |
PLB vs QTP | 40.87 | 0.00 | 2.40 | 33.53 | 0.00 | 1.61 |
PLB vs RisLAI | 0.69 | 0.00 | 0.58 | 72.94 | 0.00 | 0.03 |
PLB vs PAL | 0.00 | 0.00 | 0.00 | 100.00 | 0.00 | 0.00 |